Fixed dose combination drugs – to be banned or not to be banned
Ajay Bhargava, Vanita Bhargava and Aseem Chaturvedi explain how the FDC ban notification has adversely affected the pharma…
Author
Trends in global and Indian pharma industry
Uttam Jain, Director, Neon Laboratories, elaborates on how the pharma industry will register positive growth trends in the next…
Pharma cos brace up for a paradigm shift
With vast and quick change in culture and various global platforms, the industry is to witness a growing trend of digitisation in…
Outlook for global medicines through 2021
Growth in spending on medicines in major pharmerging markets has slowed from 2–10 percentage points over the past five years and…
‘We still have a lot of headroom to grow’
Peter DeYoung, CEO, Piramal Critical Care, talks about its recent product acquisitions from Janssen, recent advancements in the…
Pv training programme to be launched soon
The programme by MoHFW, NCC-PvPI will have a series of skill development programmes on basics and regulatory aspects of Pv
IPM clocks Rs 9,282 crores in Nov 2016
The anti-infectives was the largest therapy area for the month with a revenue of Rs 1164 crores
Indian pharma industry facing growth headwinds: ICRA
Increasing penetration, accessibility and continued new launches will help Indian pharma industry to grow in the long term
Express Pharma (Vol.12, No.5) January 1-15, 2017
India's Foremost Pharma & Biotech Magazine
Sun Pharma successfully conducts Phase-3 clinical trial for Seciera
Seciera, developed by Ocular Technologies, will be used for the treatment of dry eye